<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR253">
 <label>253.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Liu</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Gunasekaran</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Razinkov</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Sekirov</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Leng</surname>
    <given-names>E</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Asymmetrical Fc engineering greatly enhances antibody-dependent cellular cytotoxicity (ADCC) effector function and stability of the modified antibodies</article-title>
  <source>J Biol Chem</source>
  <year>2014</year>
  <volume>289</volume>
  <fpage>3571</fpage>
  <lpage>3590</lpage>
  <pub-id pub-id-type="doi">10.1074/jbc.M113.513366</pub-id>
  <?supplied-pmid 24311787?>
  <pub-id pub-id-type="pmid">24311787</pub-id>
 </element-citation>
</ref>
